D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.2B |
| 2 |
Boston Scientific
BSX
|
+$1.05B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$934M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$924M |
| 5 |
JPMorgan Chase
JPM
|
+$922M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.2B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
Palantir
PLTR
|
+$901M |
| 4 |
Netflix
NFLX
|
+$883M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$805M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.42% |
| 2 | Technology | 18.55% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 8.5% |
| 5 | Healthcare | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3101
Janux Therapeutics
JANX
$1.01B
| $1.37M | ﹤0.01% |
98,395
+65,688
| +201% | +$901K |
2025 Q4
1 quarter
|
|
3102
CALL
Liquidia Corp
LQDA
$3.07B
| $1.37M | ﹤0.01% |
36,200
-88,800
| -71% | -$3.29M |
2025 Q4
1 quarter
|
|
3103
Maze Therapeutics
MAZE
$1.53B
| $1.36M | ﹤0.01% |
45,636
+11,942
| +35% | +$527K |
2025 Q4
1 quarter
|
|
3104
PUT
Delek US
DK
$4.69B
| $1.36M | ﹤0.01% |
30,200
-51,300
| -63% | -$1.83M |
2024 Q3
6 quarters
|
|
3105
Veracyte
VCYT
$3.47B
| $1.36M | ﹤0.01% |
+42,135
| New | +$1.56M |
2026 Q1
0 quarters
|
|
3106
CALL
Oneok
OKE
$58.8B
| $1.36M | ﹤0.01% |
15,000
-55,000
| -79% | -$4.53M |
2023 Q4
9 quarters
|
|
3107
Maplebear
CART
$11.8B
| $1.35M | ﹤0.01% |
36,156
-1,292,951
| -97% | -$49M |
2023 Q3
10 quarters
|
|
3108
M3-Brigade Acquisition VI Corp
MBVI
$442M
| $1.35M | ﹤0.01% |
+134,493
| New | +$1.36M |
2026 Q1
0 quarters
|
|
3109
CALL
Halozyme
HALO
$13.8B
| $1.35M | ﹤0.01% |
+20,900
| New | +$1.47M |
2026 Q1
0 quarters
|
|
3110
PUT
Sweetgreen
SG
$1.2B
| $1.35M | ﹤0.01% |
260,100
+231,500
| +809% | +$1.41M |
2025 Q2
3 quarters
|
|
3111
Core Natural Resources Inc
CNR
$4.48B
| $1.35M | ﹤0.01% |
12,882
+10,094
| +362% | +$961K |
2025 Q3
2 quarters
|
|
3112
Avery Dennison
AVY
$13.3B
| $1.35M | ﹤0.01% |
7,805
-75,825
| -91% | -$13.9M |
2024 Q1
8 quarters
|
|
3113
CALL
St. Joe Company
JOE
$3.89B
| $1.34M | ﹤0.01% |
+21,400
| New | +$1.43M |
2026 Q1
0 quarters
|
|
3114
James Hardie Industries
JHX
$15B
| $1.34M | ﹤0.01% |
+70,931
| New | +$1.6M |
2026 Q1
0 quarters
|
|
3115
CALL
State Street
STT
$45.5B
| $1.34M | ﹤0.01% |
10,600
-37,200
| -78% | -$4.76M |
2024 Q3
6 quarters
|
|
3116
Choiceone Financial
COFS
$495M
| $1.34M | ﹤0.01% |
47,611
+2,274
| +5% | +$65.2K |
2025 Q4
1 quarter
|
|
3117
Global X US Infrastructure Development ETF
PAVE
$13.5B
| $1.34M | ﹤0.01% |
+26,310
| New | +$1.37M |
2026 Q1
0 quarters
|
|
3118
BlackRock ESG Capital Allocation Term Trust
ECAT
$1.31B
| $1.34M | ﹤0.01% |
98,455
| – | – |
2023 Q2
11 quarters
|
|
3119
Huron Consulting
HURN
$2.78B
| $1.34M | ﹤0.01% |
10,481
-2,860
| -21% | -$430K |
2015 Q3
42 quarters
|
|
3120
PUT
Globalstar
GSAT
$10.7B
| $1.34M | ﹤0.01% |
+20,100
| New | +$1.23M |
2026 Q1
0 quarters
|
|
3121
CALL
Alexandria Real Estate Equities
ARE
$7.16B
| $1.33M | ﹤0.01% |
28,700
-37,800
| -57% | -$1.99M |
2025 Q2
3 quarters
|
|
3122
Monolithic Power Systems
MPWR
$59.5B
| $1.33M | ﹤0.01% |
1,217
-131
| -10% | -$143K |
2022 Q3
14 quarters
|
|
3123
CALL
Block Inc
XYZ
$46.8B
| $1.33M | ﹤0.01% |
22,100
-147,100
| -87% | -$8.94M |
2017 Q1
36 quarters
|
|
3124
PUT
BlackSky Technology
BKSY
$709M
| $1.33M | ﹤0.01% |
52,800
| – | – |
2025 Q3
2 quarters
|
|
3125
CALL
Forward Air
FWRD
$508M
| $1.33M | ﹤0.01% |
79,500
-16,300
| -17% | -$397K |
2024 Q1
8 quarters
|
|
Similar funds
D.E. Shaw & Co's Q1 2026 Portfolio in Review
As of Q1 2026, D.E. Shaw & Co held 5,226 positions worth $166B, down 8.8% from $182B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $5.92B in Q1 2026, closing 756 positions and reducing 1,922 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $805M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 36% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in Venture Global Inc worth $211M.
- D.E. Shaw & Co's largest Q1 2026 buy was Venture Global Inc: 13,410,074 shares worth $211M.
- D.E. Shaw & Co added most to Broadcom in Q1 2026, an estimated $1.2B increase.
- D.E. Shaw & Co's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.2B.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $805M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $166B portfolio in Q1 2026.
- D.E. Shaw & Co opened 685 new positions and closed 756 in Q1 2026.
- D.E. Shaw & Co's portfolio value fell 8.8% quarter-over-quarter to $166B.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.